iShares Nasdaq Biotechnology [IBB] is traded in USA and was established on January 21, 2018. The fund is classified under Health
category within iShares
family. iShares Nasdaq Biotechnology currently have 9.93 B in assets under management (AUM). , while the total return for the last 3 years was 2.01%.
Check iShares Nasdaq Probability Of Bankruptcy